Dr. Peng got his Bachelor and Master in the College of Life Sciences, Beijing Normal University. He got his Public Policy and Management Discipline Ph.D. degree in the Institute of Education (Mentor, Dr. Jian Lin), Tsinghua University. He was a visiting scholar in the Global Engineering Education Collaboratory (GEEC), College of Engineering, Purdue University (West Lafayette, IN). Dr. Peng worked at the School of Life Sciences at Tsinghua and Westlake Institute for Advanced Study (WIAS). In WIAS, he worked for Dr. Yigong Shi as Dean Assistant to help on setting up of Westlake University. Before joining SineuGene, he was the CEO of Tianyin Health Development Co., Ltd, Nanjing, Jiangsu, China. Dr. Peng's biological background, business management skills, entrepreneurship ensure his leadership at SineuGene.

Dr. Wei Guogothis bachelor in biochemistry, Nanjing University, China and his Ph.D. in Institute of Neuroscience,Chinese Academy of Sciences, Shanghai. After his postdoc training with Dr. Bai Lu in School of Life Sciences, Tsinghua University, he worked as a full-time employee in the neurodegenerative disease department, GlaxoSmithKline (GSK).Prior to co-founding SineuGene, he was an Associate Professor at School of Pharmaceutical Sciences, Tsinghua University, and helped to managea research team with more than30 people. He has studied neurodegenerative diseases and has been involved in the innovative drug development for the devastating diseases for more than 20 years. He has published his cutting-edge research inCell Res.,Nat. Comm., and others as a corresponding author. He also holds a number of international PCT patents. He had also been involved in the establishments of several innovative pharmaceutical companies and helped build R&D pipelines. Dr. Guo’s leadership and enriched experiences in basic research and translational medicine ensure his successful management of R&D at SineuGene.